1. IDENTIFY BPR REQUIREMENTS FULFILL BPR OBLIGATIONS
Flow Chart 4.0
Step-By-Step Navigator
CHAPTER 4.8 Maintain Records
END OF PROCESS
Identify a Substance /
Mixture
Identify an Article
CHAPTER 4.7 Provide Further Information to Customers
CHAPTER 4.1 Identify Biocidal Product / Treated Article
CHAPTER 4.2 Identify Product-Type
CHAPTER 4.3 Identify Roles and Obligations
CHAPTER 4.4 Check AS Status / Transitional Measures
CHAPTER 4.5 Substitute/Eliminate AS as required
CHAPTER 4.6 Label BP & TA as Required
IDENTIFY BPR REQUIREMENTS
FULFILL BPR OBLIGATIONS
Label a BP
See Flow Chart 4.4.1
Label a TA
Use a BP
See Flow Chart 4.4.2
See Flow Chart 4.4.4
Use an In Situ BP
Market a TA
See Flow Chart 4.1.1
See Flow Chart 4.1.2
See Flow Chart 4.6.2
See Chapter 4.6.1
Product is an “Article” under REACH?
YES NO
 Chapter 2.1, “Article”, “Substance”, “Mixture”

2. Flow Chart 4.1.1 END OF PROCESS
Identify BP / TA – REACH Articles
Product is neither BP nor TA (Out of scope of BPR)
Product is Treated Article with biocidal property or biocidal function
Product is Biocidal Product
Does finished product intentionally incorporate biocidal product?
Does product have a biocidal property or function relevant to finished product?
Does product have a primary biocidal function?
YES NO
 Chapter 2.1, “Intentionally Incorporating”
 Chapter 2.1, “Biocidal Property”, “Biocidal Function”
 Chapter 2.1, “Primary biocidal function” Is
finished product
treated “short-term” with biocidal product?
Product is Treated Article without biocidal function
 Chapter 2.1, “Treated with”
Go to Chapter 4.2
END OF PROCESS
used to generate active substance(s)?
Product is Biocidal Product for generation of in situ active substance(s)
 Chapter 2.1, “In situ generated active substances”

3. Flow Chart 4.1.2 END OF PROCESS
BP / TA Identification: Substances & Mixtures
Product is Biocidal Product
Product is Treated Article
Product is neither BP nor TA (Out of scope of BPR)
Does product contain AS
and have biocidal function rel- evant to finished
product?
Is product treated with, or does it intentionally incorporate, biocidal product?
YES NO
 Chapter 2.1, “Biocidal function”
 Chapter 2.1, “Intentionally Incorporating”, “Treated with”
Is Active Substance generated “in situ” from precursors?
 Chapter 2.1, “In situ generated active substances”
Precursor combination is Biocidal Product
END OF PROCESS
Go to Chapter 4.2

4. AS may be used in BPs for all PTs
Flow Chart 4.4.1
Use a Biocidal Product NO
YES
 Chapter 4.4.5
Is AS/PT
approved on the Union List?
Is supplier listed for the AS/PT combination on the Article 95 List?
 Chapter
 Chapter 4.4.6
Was AS/PT in the Review Programme before 1 Sep 2016?
AS may be used for the specified PT (pending approval decision if AS/PT is in the Review Programme)
 Chapter 4.4.4
Is AS
on the Annex I list
under Categories
1 to 5 or 7?
AS may be used in BPs for all PTs
AS may not be used in a BP since1 Sept 2015, unless a new approval application is approved
Go to Chapter 4.5
under Category 6?

5. TA may be marketed without time limit
Is AS listed
in BPR Annex I? NO
YES
 Chapter 4.4.4
TA may be marketed without time limit
TA may not be marketed after 1 Mar 2017, unless a new application is approved
Flow Chart 4.4.3
Market a Treated Article
TA may be marketed, pending approval decision
 Chapter 4.4.5
 Chapter 4.4.8
 Chapter 4.4.6
Is non-approval
decision on the AS/PT made after 1 Sep 2016?
Is AS/PT in the Review Programme before 1 Sep 2016?
Is AS approved on the Union List for the relevant PT?
TA may not be marketed after 180 days after non-approval decision, unless a new application is approved
Is a non-approval decision on the AS/PT made before 1 Sep 2016?
Go to Chapter 4.5

6. Treated Article: Labelling Obligations
Flow Chart 4.6.2
Treated Article: Labelling Obligations
Is a claim made regarding the biocidal properties of the TA?
Does an AS used require labelling as a condition of approval? NO
YES
 Chapter 2.1, “Claim”
 Chapter 4.6.4
Does the TA intentionally incorporate a Biocidal Product?
 Chapter 4.6.3
Provide labelling that includes :
Statement that the TA incorporates biocidal products
Names of all active substances contained in the biocidal products
Names of all nanomaterials contained in the biocidal products;
Relevant instructions and any precautions for use.
 Chapter 4.6.5
Has a biocidal property of the TA been substantiated?
TA may be placed on the market without labelling
Include on labelling:
Biocidal property attributed to the treated article
TA may be placed on the market with labelling
Go to Chapter 4.7